期刊文献+

多囊卵巢综合征患者体外受精-胚胎移植妊娠结局的影响因素及预测 被引量:24

Impact factors and prediction of pregnancy outcome of in vitro fertilization-embryo transfer in patients with polycystic ovary syndrome
原文传递
导出
摘要 目的探讨影响多囊卵巢综合征(PCOS)患者体外受精-胚胎移植(IVF-ET)妊娠结局的相关因素及预测价值。方法选取2015年5月至2017年12月PCOS进行IVF-ET并有妊娠结局的104例患者作为研究对象。根据移植后第28天超声结果分为临床妊娠成功组(41例)和临床妊娠失败组(63例)。比较两组患者的年龄、妊娠前体质指数(BMI)、抗苗勒管激素(AMH)、基础卵泡刺激素(FSH)、黄体生成素(LH)、LH/FSH值和雌二醇(E2),并进行多因素分析,建立临床妊娠的全变量风险预测模型。结果单因素分析显示,临床妊娠成功组的年龄(P=0.004)、LH/FSH值(P=0.009)、Gn用量(P=0.013)小于临床妊娠失败组,而临床妊娠成功组的FSH水平(P=0.013)、获卵总数(P=0.018)、hCG日子宫内膜厚度(P=0.005)、正常受精率(P=0.004)高于临床妊娠失败组;logistic多因素分析显示,年龄(OR=0.638,95%CI:0.480~0.847,P=0.002)、LH/FSH(OR=0.106,95%CI:0.026~0.423,P=0.002)、Gn用量(OR=0.961,95%CI:0.927~0.995)是影响IVF-ET治疗PCOS患者妊娠结局的独立危险因素,FSH(OR=1.276,95%CI:1.199~1.359)、正常受精率(OR=1.146,95%CI:1.025~1.118)是独立保护因素。以临床妊娠是否成功为因变量,年龄、FSH、LH/FSH值为自变量,采用逐步回归法,临床妊娠结局预测模型:P=1/(1+e-(-3.136-0.450×年龄-0.244×FSH-2.248×(LH/FSH)-0.040×Gn用量+1.146×受精率))。此方程与患者临床妊娠结局做ROC曲线,曲线下面积为0.971,95%CI:0.918~0.987。结论年龄、FSH、LH/FSH值是影响IVF-ET治疗PCOS患者不孕妊娠结局的独立影响因素,三者联合有望用于临床妊娠结局的预测。 Objective To investigate the factors and predictive value of in vitro fertilization-embryo transform(IVF-ET)pregnancy outcomes in patients with polycystic ovary syndrome(PCOS).Methods A total of 104 patients who were diagnosed of PCOS and received IVF-ET from May 2014 to December 2017 were enrolled.Patients were divided into 2 groups:successful clinical pregnancy group(n=41)and unsuccessful clinical pregnancy group(n=63).Ages,BMI,AMH,FSH,LH,LH/FSH and E2 were compared and a multivariate analysis was performed to investigate the risk factors and establish a model for pregnancy outcome prediction by logistic regression.Results Single factor analysis showed that the ages(P=0.004),LH/FSH(P=0.009)and Gn dosage(P=0.013)of patients in the successful clinical pregnancy group were lower than those in the unsuccessful group,while the FSH level(P=0.013),total number of oocytes(P=0.018),endometrial thickness at the day of administration of hCG(P=0.005),fertilization rate(P=0.004)were higher in successful clinical pregnancy group.Logistic multivariate analysis showed that age(OR=0.638,95%CI:0.480~0.847,P=0.002),LH/FSH(OR=0.106,95%CI:0.026~0.423,P=0.002)and Gn dosage(OR=0.961,95%CI:0.927-0.995)were independent risk factors,FSH(OR=1.276,95%CI:1.199~1.359,P=0.006)and fertilization rate(OR=1.146,95%CI:1.025~1.118)were independent protective factors.The prediction model(P)acquired by the stepwise method for clinical pregnancy probability was:P=1/(1+e-(-3.136-0.450×ages-0.244×FSH-2.248×(LH/FSH)-0.040×Gn dosage+1.146×fertilization rate)).The area under ROC curve was 0.971(95%CI:0.918~0.987).Conclusion Age,LH/FSH and FSH were the independent factors affecting the pregnancy outcome of IVF-ET in patients with PCOS,and the combination of the three is expected to be used to predict the outcome of clinical pregnancy.
作者 周晓燕 汤美玲 马娟 王葳 沈澍 ZHOU Xiaoyan;TANG Meiling;MA Juan;WANG Wei;CHEN Shu(Department of Reproductive Medicine,Wanbei Coal Electricity Group Company General Hospital,Suizhou,Anhui 243000,China)
出处 《中国妇产科临床杂志》 CSCD 北大核心 2020年第4期370-373,共4页 Chinese Journal of Clinical Obstetrics and Gynecology
关键词 多囊卵巢综合征 辅助生殖技术 妊娠结局 预测模型 影响因素 polycystic ovary syndrome assisted reproductive technique pregnancy outcome prediction model impact factor
  • 相关文献

参考文献6

二级参考文献60

  • 1张学红,李丽斐,赵丽辉,石馨,贾学玲.应用不同剂量长效GnRHa(达菲林)降调节的临床效果分析[J].生殖与避孕,2005,25(7):435-437. 被引量:27
  • 2乔杰,王丽娜.辅助生殖异位妊娠相关因素分析[J].中国实用妇科与产科杂志,2006,22(12):894-897. 被引量:23
  • 3卢先艳,胡娅莉,孙海翔.GnRHa降调节后月经第3天的FSH/LH比值预测卵巢的反应性[J].中国妇产科临床杂志,2007,8(4):249-251. 被引量:16
  • 4Ashkenazi J, Farhi J, Orvieto R, et al. Polycystic ovary syndrome patients as oocyte donors: the effect of ovarian stimulation protocol on the implantation rate of the recipient[J]. Fertil Steril, 1995, 64 (3): 564-7.
  • 5Shoham Z. The clinical therapeutic window for luteinizing hormone in controlled ovarian stimulation[J]. Fertil Steril, 2002, 77(6): 1170-7.
  • 6Orvieto R, Meltcer S, Liberty G, et al. Does day-3 LH/FSH ratio influence in vitro fertilization outcome in PCOS patients undergoing controlled ovarian hyperstimulation with different GnRH-analogue [J]? Gynecol Endocrinol, 2012, 28(6): 422-4.
  • 7Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome[J]. Fertil Steril, 2004, 81 (1): 19-25.
  • 8Regan L, Owen [J, Jacobs HS. Hypersecretion of luteinising hormone, infertility, and miscarriage [J]. Lancet, 1990, 336(8724): 1141-4.
  • 9Balen AH, Tan SL, Jacobs HS. Hypersecretion of luteinising hormone: a significant cause of infertility and miscarriage [J]. Br J Obstet Gynaecol, 1993, 100(12): 1082-9.
  • 10Balen AH, Tan SL, Macdougall J, et al. Miscarriage rates following in-vitro fertilization are increased in women with polycystic ovaries and reduced by pituitary desensitization with buserelin [J]. Hum Reprod, 1993, 8(6): 959-64.

共引文献91

同被引文献221

引证文献24

二级引证文献128

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部